HOMA-IR
Females, Age 30-39
The median HOMA-IR for US females aged 30-39 is 2.2, with 90% of the population falling between 0.79 and 9.18.
NHANES 2017-March 2020 Pre-Pandemic 2017-2020 · Sample size: 345 participants · Unit: index
Percentile Distribution
| Percentile | P5 | P10 | P25 | P50 | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|
| Value (index) | 0.8 | 0.9 | 1.3 | 2.2 | 4.2 | 7.4 | 9.2 |
| Percentile | Value (index) |
|---|---|
| P5 | 0.8 |
| P10 | 0.9 |
| P25 | 1.3 |
| P50 | 2.2 |
| P75 | 4.2 |
| P90 | 7.4 |
| P95 | 9.2 |
0.8 1.3 2.2 4.2 9.2
P5 P25 P50 P75 P95
Data and Methodology
- Dataset
- NHANES 2017-March 2020 Pre-Pandemic ( NHANES 2017-2020 2020 , Survey-weighted percentiles from fasting subsample)
- Survey years
- 2017-2020
- Sample size
- 345 participants
- Reference population
- US civilian non-institutionalized females aged 30-39 from NHANES 2017-March 2020. Includes the full population (not restricted to healthy individuals) to reflect the population distribution.
- Exclusion criteria
-
- Missing fasting insulin or fasting glucose measurement required to derive HOMA-IR
- Missing or zero fasting sample weight (WTSAF)
- Age outside 30-39 range
- Notes
- Percentiles computed using the combined pre-pandemic fasting-subsample weight (WTSAFPRP). HOMA-IR derived as fasting insulin (LBXIN) x fasting glucose (LBXGLU) / 405 using fasting-subsample data.